Risk factors and predisposing genes for mild cognitive impairment in patients with type 2 diabetes mellitus
Xiuying Qi,Xianhai Meng,Yun Xie,Dan Qian,Yuying Zhou,Xia Zhao,Fangfang Shen
DOI: https://doi.org/10.1016/j.jalz.2010.05.1510
2010-01-01
Abstract:The study was carried out in order to explore risk factors and predisposing genes for mild cognitive impairment in patients with type 2 diabetes, and provide scientific basis for preventing Alzheimer's disease. A hospital-based case-control study was conducted in Tianjin, China from May, 2008 to March, 2009. The subjects included 248 type 2 diabetic patients, in which 60 patients with mild cognitive impairment were confirmed by using Mini-mental State Examination scale and clock drawing test and constituted case group and 188 patients without cognitive impairment constituted control group. The information of subjects was collected by using self-made questionnaire, which including demographic data, disease history, disease family history, behavior pattern, clinical data, laboratory data. Depression and anxiety of subjects were assessed by Hospital Anxiety and Depression Scale. Blood samples were collected from 60 cases and 120 controls and the polymorphisms of APOE gene and promoter G/A−308 of TNF-α gene were detected by PCR-RFLP. The risk factors were analyzed by logistic regression and ORs value and its 95%CIs were calculated. The differences of the frequencies of alleles of APOE and TNF-α genes between case and control groups were statistical significance (Table1,2). The adjusted ORs of logistic regression analyses showed that the risk of cognitive impairment increased significantly among type 2 diabetic patients who were older (OR = 5.889, 95% CI: 2.744-12.639), anxious (OR = 4.205, 95% CI: 1.607-11.004), longer diabetic course (OR = 3.008, 95% CI: 1.638-5.524), epsilon 4 carriers of APOE gene (OR = 4.340, 95% CI: 1.589-11.854), bad glycemia control (OR = 3.323, 95% CI: 1.419-7.783) and allele A carriers of TNF-α gene (OR = 3.931, 95% CI:1.366-11.315), and decreased significantly among type 2 diabetic patients who had higher education level (OR = 0.396, 95% CI: 0.232-0.676). No associations were found between cognitive impairment and gender, history of hypertension, family histories of hypertension and diabetes, diabetic peripheral neuropathy, diabetic retinopathy, diabetic nephropathy, smoking, drinking, depression, body mass index, serum glucose and lipids. The risk factors of cognitive impairment in type 2 diabetic patients were older, anxious, longer diabetic course, epsilon 4 carriers of APOE gene, bad glycemia control, allele A carriers of TNF-α gene, while higher education level was the protective factor for cognitive impairment.